… Current therapeutic options in patients with HF are largely on the basis of cardiovascular …
a call for action to ensure that novel therapeutic options are assessed in dedicated trials in the …

… Organization suggests that the cardiovascular diseases (CVDs) are the major cause of
mortality and account for two-thirds of the deaths all over the world. These diseases kill about 17 …

… approach for patients who suffering from cardiovascular diseases. In the current review, we
summarized current therapeutic strategies based on stem cells for cardiovascular diseases. J…

… available pharmacological option may offer a very cost effective therapeutic option, large-…
allopurinol as a potential therapeutic option in the management of cardiovascular disease. …

… Optimizing dyslipidemia management to both prevent the onset of cardiovascular disease
… therapeutic options for optimizing the care of individuals who are at risk of incident ASCVD. …

… Presently, these therapeutic options are mainly targeted for patients with progressive CVD …
the common therapeutic strategy aims at an optimal management of cardiovascular risk factors…

The association between increased uric acid (UA) levels and cardiovascular disease (CVD)
has been observed and studied for many decades. The value of UA as an independent …

… interest for the treatment of several cardiovascular diseases. The biological system of the
NO/… current options to modulate NO bioavailability for the treatment of cardiovascular disease, …

… cardiovascular disease… cardiovascular disease in patients on optimal statin therapy [45].
The most powerful evidence for a direct contribution of elevated Lp(a) to cardiovascular disease …

… for metabolic therapy in ischemic heart disease and heart failure … of the metabolic therapeutic
options currently available. … heart disease and highlight the need of optimization of cardiac …